Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Artificial intelligence in the management of prostate cancer

Nature Reviews Urology (2024)Cite this article

Subjects

Artificial intelligence (AI) is transforming prostate cancer management from diagnosis to treatment. AI tools have been designed for the analysis of digitized histopathology and MRI scans, generation of synthetic CT scans and improvement of robotic surgical outcomes. This progress underscores the need for regulation and the development of safe, ethical and non-biased software.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rabilloud, N. et al. Deep learning methodologies applied to digital pathology in prostate cancer: a systematic review. Diagnostics 13, 2676 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bulten, W. et al. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the Panda Challenge. Nat. Med. 28, 154–163 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Turkbey, B. & Haider, M. A. Deep learning-based artificial intelligence applications in prostate MRI: brief summary. Br. J. Radiol. 95, 20210563 (2022).

    Article  PubMed  Google Scholar 

  4. Mehta, P. et al. AutoProstate: towards automated reporting of prostate MRI for prostate cancer assessment using deep learning. Cancers 13, 6138 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hung, A. J. et al. Utilizing machine learning and automated performance metrics to evaluate robot-assisted radical prostatectomy performance and predict outcomes. J. Endourol. 32, 438–444 (2018).

    Article  PubMed  Google Scholar 

  6. Soomro, N. MASTERY. NHS Health Research Authority https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/mastery/ (2020).

  7. Checcucci, E. et al. Three-dimensional automatic artificial intelligence driven augmented-reality selective biopsy during nerve-sparing robot-assisted radical prostatectomy: a feasibility and accuracy study. Asian J. Urol. 10, 407–415 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Autret, D., Guillerminet, C., Roussel, A., Cossec-Kerloc’h, E. & Dufreneix, S. Comparison of four synthetic CT generators for brain and prostate MR-only workflow in radiotherapy. Radiat. Oncol. 18, 146 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Zhang, P. & Kamel Boulos, M. N. Generative AI in medicine and healthcare: promises, opportunities and challenges. Future Internet 15, 286 (2023).

    Article  CAS  Google Scholar 

  10. Connor, M. J., Dasgupta, P., Ahmed, H. U. & Raza, A. Autonomous surgery in the era of robotic urology: friend or foe of the future surgeon? Nat. Rev. Urol. 17, 643–649 (2020).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This paper has been possible through the support of the Hinduja-King’s Academy and Alberto Recordati through philanthropic funding, 5-year programme grants from Responsible AI UK and Trustworthy Autonomous Systems Hub and funding from UK Research and Innovation (UKRI)/the Engineering and Physical Sciences Research Council (EPSRC).

Author information

Authors and Affiliations

  1. Faculty of Life Sciences and Medicine, King’s College London, London, UK

    Raghav Khanna, Nicholas Raison & Prokar Dasgupta

  2. School of Biomedical Engineering and Imaging Sciences, King’s College London, London, UK

    Alejandro Granados Martinez & Sebastien Ourselin

  3. San Raffaele Hospital, Milan, Italy

    Alberto Briganti & Francesco Montorsi

Authors
  1. Raghav Khanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alejandro Granados Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicholas Raison
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sebastien Ourselin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alberto Briganti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesco Montorsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Prokar Dasgupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raghav Khanna.

Ethics declarations

Competing interests

P.D. is an advisor to Proximie and Chief Medical Officer of MysteryVibe. S.O. is an advisor to Proximie and Eliatra, and co-founder and non-executive director of Hypervision Surgical. The other authors declare no competing interests.

Additional information

Related links

Responsible AI UK: https://rai.ac.uk/

Trustworthy Autonomous Systems Hub: https://tas.ac.uk/

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khanna, R., Martinez, A.G., Raison, N. et al. Artificial intelligence in the management of prostate cancer. Nat Rev Urol (2024). https://doi.org/10.1038/s41585-024-00938-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41585-024-00938-z

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing